Global Wound Care Biologics Market Insights, Forecast to 2025
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.
With the development of medical technology level, more and more companies participate in this industry.
The global Wound Care Biologics market is valued at 2580 million US$ in 2018 and will reach 5810 million US$ by the end of 2025, growing at a CAGR of 10.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Wound Care Biologics market based on company, product type, end user and key regions.
This report studies the global market size of Wound Care Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Wound Care Biologics in these regions.
This research report categorizes the global Wound Care Biologics market by top players/brands, region, type and end user. This report also studies the global Wound Care Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Smith & Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Market size by Product
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Market size by End User
Acute Wounds
Chronic Wounds
Surgical Wounds
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Wound Care Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Wound Care Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Wound Care Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Wound Care Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Wound Care Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Wound Care Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.
With the development of medical technology level, more and more companies participate in this industry.
The global Wound Care Biologics market is valued at 2580 million US$ in 2018 and will reach 5810 million US$ by the end of 2025, growing at a CAGR of 10.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Wound Care Biologics market based on company, product type, end user and key regions.
This report studies the global market size of Wound Care Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Wound Care Biologics in these regions.
This research report categorizes the global Wound Care Biologics market by top players/brands, region, type and end user. This report also studies the global Wound Care Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Smith & Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Market size by Product
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Market size by End User
Acute Wounds
Chronic Wounds
Surgical Wounds
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Wound Care Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Wound Care Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Wound Care Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Wound Care Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Wound Care Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Wound Care Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
